| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein phosphatase binding | FOXO1 CACNA1C CEACAM5 VRK3 CEACAM8 CEACAM6 MAGI3 CPD PPP6R1 CEACAM1 PPP6R2 PPP6R3 | 8.65e-08 | 210 | 154 | 12 | GO:0019903 |
| GeneOntologyMolecularFunction | phosphatase binding | FOXO1 CACNA1C CEACAM5 VRK3 CEACAM8 CEACAM6 MAGI3 CPD PPP6R1 CEACAM1 PPP6R2 PPP6R3 | 1.01e-06 | 264 | 154 | 12 | GO:0019902 |
| GeneOntologyMolecularFunction | GPI anchor binding | 2.69e-05 | 23 | 154 | 4 | GO:0034235 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | CEACAM5 SLC38A9 SLC26A4 CEACAM8 CEACAM6 GRIK1 GRIK2 CEACAM1 SLC7A1 | 3.36e-05 | 207 | 154 | 9 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | CEACAM5 SLC38A9 SLC26A4 CEACAM8 CEACAM6 GRIK1 GRIK2 CEACAM1 SLC7A1 | 3.49e-05 | 208 | 154 | 9 | GO:0005342 |
| GeneOntologyMolecularFunction | calcium ion binding | PCDHGA3 FAT3 PCDHB13 SYT9 PCDHB3 PCDHA8 PCDHA6 CDHR5 PCDH17 CEMIP2 FAT2 CELSR2 PCDHGB4 DCHS1 CDH3 PCDH1 PCDH18 | 6.87e-05 | 749 | 154 | 17 | GO:0005509 |
| GeneOntologyMolecularFunction | filamin binding | 6.95e-05 | 29 | 154 | 4 | GO:0031005 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 1.32e-04 | 34 | 154 | 4 | GO:0015125 | |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 1.54e-04 | 14 | 154 | 3 | GO:0005130 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 3.38e-04 | 120 | 154 | 6 | GO:0008013 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | CEACAM5 SLC38A9 SLC26A4 CEACAM8 CEACAM6 GRIK1 GRIK2 CEACAM1 SLC7A1 | 4.62e-04 | 293 | 154 | 9 | GO:0008514 |
| GeneOntologyMolecularFunction | glycolipid binding | 5.50e-04 | 49 | 154 | 4 | GO:0051861 | |
| GeneOntologyMolecularFunction | selenocysteine insertion sequence binding | 8.69e-04 | 6 | 154 | 2 | GO:0035368 | |
| GeneOntologyMolecularFunction | kainate selective glutamate receptor activity | 8.69e-04 | 6 | 154 | 2 | GO:0015277 | |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 1.21e-03 | 7 | 154 | 2 | GO:0005234 | |
| GeneOntologyMolecularFunction | actin binding | LIMA1 CEACAM5 MYO9A CEACAM8 CEACAM6 GBP3 CEACAM1 SIPA1L1 TLN2 MICAL3 LIMCH1 | 1.25e-03 | 479 | 154 | 11 | GO:0003779 |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.42e-03 | 29 | 154 | 3 | GO:0035325 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CEACAM5 PCDHGA3 FAT3 PCDHB13 CEACAM8 PCDHB3 CEACAM6 PCDHA8 PCDHA6 CDHR5 PCDH17 CEACAM1 FAT2 CELSR2 PCDHGB4 DCHS1 CDH3 PCDH1 PCDH18 | 2.01e-16 | 187 | 154 | 19 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CEACAM5 PCDHGA3 FAT3 PCDHB13 CEACAM8 PCDHB3 CEACAM6 PCDHA8 PCDHA6 CDHR5 PCDH17 CEACAM1 FAT2 CELSR2 PCDHGB4 DCHS1 CDH3 PCDH1 PCDH18 | 2.38e-12 | 313 | 154 | 19 | GO:0098742 |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 1.30e-07 | 53 | 154 | 7 | GO:0016339 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CEACAM5 PCDHGA3 FAT3 PCDHB13 CEACAM8 PCDHB3 CEACAM6 PCDHA8 PCDHA6 CDHR5 TESPA1 PCDH17 CEACAM1 SLC7A1 FAT2 CELSR2 PCDHGB4 DCHS1 TLN2 LOXL3 PRKCZ CDH3 PCDH1 PCDH18 | 1.50e-06 | 1077 | 154 | 24 | GO:0098609 |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 2.82e-06 | 14 | 154 | 4 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 3.83e-06 | 15 | 154 | 4 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 3.83e-06 | 15 | 154 | 4 | GO:1903387 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 5.07e-06 | 16 | 154 | 4 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 6.59e-06 | 17 | 154 | 4 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 6.59e-06 | 17 | 154 | 4 | GO:1901143 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 8.43e-06 | 18 | 154 | 4 | GO:1903385 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 8.94e-06 | 38 | 154 | 5 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 1.32e-05 | 20 | 154 | 4 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 1.62e-05 | 21 | 154 | 4 | GO:0070345 | |
| GeneOntologyBiologicalProcess | regulation of phosphatase activity | 1.92e-05 | 74 | 154 | 6 | GO:0010921 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 2.33e-05 | 46 | 154 | 5 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 2.33e-05 | 46 | 154 | 5 | GO:0072574 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 3.18e-05 | 49 | 154 | 5 | GO:0072576 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | MYBBP1A RPS6KA5 BICRA ASH1L NSD1 NBN CHD8 TEX15 BCL7A KMT2E TRIP12 MIER1 IWS1 WDHD1 BRCA2 UBR5 NCOA1 | 4.04e-05 | 741 | 154 | 17 | GO:0006338 |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 4.59e-05 | 27 | 154 | 4 | GO:0070344 | |
| GeneOntologyBiologicalProcess | heterochromatin boundary formation | 5.54e-05 | 2 | 154 | 2 | GO:0033696 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 9.13e-05 | 32 | 154 | 4 | GO:0070341 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 1.03e-04 | 33 | 154 | 4 | GO:2000252 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 1.16e-04 | 34 | 154 | 4 | GO:0043116 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 1.31e-04 | 35 | 154 | 4 | GO:1901142 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | MYBBP1A RPS6KA5 BICRA ASH1L NSD1 NBN CHD8 TEX15 BCL7A KMT2E TRIP12 MIER1 IWS1 SUGT1 WDHD1 BRCA2 UBR5 TAF7L NCOA1 | 1.70e-04 | 999 | 154 | 19 | GO:0071824 |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 1.74e-04 | 15 | 154 | 3 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.74e-04 | 15 | 154 | 3 | GO:0002859 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 2.01e-04 | 39 | 154 | 4 | GO:0045717 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 2.57e-04 | 17 | 154 | 3 | GO:0038158 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell proliferation | 3.04e-04 | 226 | 154 | 8 | GO:0050680 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 3.51e-04 | 45 | 154 | 4 | GO:0048521 | |
| GeneOntologyBiologicalProcess | chromatin organization | MYBBP1A RPS6KA5 BICRA ASH1L NSD1 NBN CHD8 TEX15 BCL7A KMT2E TRIP12 MIER1 IWS1 WDHD1 BRCA2 UBR5 NCOA1 | 3.91e-04 | 896 | 154 | 17 | GO:0006325 |
| GeneOntologyBiologicalProcess | regulation of dephosphorylation | 4.03e-04 | 128 | 154 | 6 | GO:0035303 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 4.15e-04 | 47 | 154 | 4 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 4.92e-04 | 21 | 154 | 3 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 4.92e-04 | 21 | 154 | 3 | GO:0002838 | |
| GeneOntologyBiologicalProcess | regulation of mammary gland epithelial cell proliferation | 4.92e-04 | 21 | 154 | 3 | GO:0033599 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 5.66e-04 | 22 | 154 | 3 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 6.03e-04 | 91 | 154 | 5 | GO:0051055 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 6.48e-04 | 23 | 154 | 3 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 6.48e-04 | 23 | 154 | 3 | GO:0002858 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 7.36e-04 | 24 | 154 | 3 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 7.36e-04 | 24 | 154 | 3 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 7.36e-04 | 24 | 154 | 3 | GO:0002420 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 5.46e-06 | 16 | 159 | 4 | GO:0070021 | |
| GeneOntologyCellularComponent | cell-cell junction | CEACAM5 ASH1L CEACAM8 CEACAM6 MAGI3 CEACAM1 KIAA1210 FAT2 HPN NHS TLN2 PRKCZ CDH3 PCDH1 | 1.75e-04 | 591 | 159 | 14 | GO:0005911 |
| GeneOntologyCellularComponent | apical part of cell | CEACAM5 DYNC2H1 SLC26A4 CEACAM8 DAB2 CEACAM6 CDHR5 CEACAM1 SLC7A1 KCNB1 HPN DCHS1 NHS PRKCZ | 1.78e-04 | 592 | 159 | 14 | GO:0045177 |
| GeneOntologyCellularComponent | apical plasma membrane | CEACAM5 SLC26A4 CEACAM8 DAB2 CEACAM6 CDHR5 CEACAM1 SLC7A1 KCNB1 HPN NHS PRKCZ | 3.61e-04 | 487 | 159 | 12 | GO:0016324 |
| GeneOntologyCellularComponent | lateral plasma membrane | 6.24e-04 | 90 | 159 | 5 | GO:0016328 | |
| GeneOntologyCellularComponent | host cell part | 8.45e-04 | 6 | 159 | 2 | GO:0033643 | |
| GeneOntologyCellularComponent | host intracellular part | 8.45e-04 | 6 | 159 | 2 | GO:0033646 | |
| GeneOntologyCellularComponent | host cell cytoplasm part | 8.45e-04 | 6 | 159 | 2 | GO:0033655 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole | 8.45e-04 | 6 | 159 | 2 | GO:0020003 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole membrane | 8.45e-04 | 6 | 159 | 2 | GO:0020005 | |
| GeneOntologyCellularComponent | host intracellular region | 8.45e-04 | 6 | 159 | 2 | GO:0043656 | |
| GeneOntologyCellularComponent | host cell cytoplasm | 8.45e-04 | 6 | 159 | 2 | GO:0030430 | |
| GeneOntologyCellularComponent | kainate selective glutamate receptor complex | 8.45e-04 | 6 | 159 | 2 | GO:0032983 | |
| GeneOntologyCellularComponent | anchoring junction | LIMA1 CEACAM5 ASH1L CEACAM8 DAB2 CEACAM6 MAGI3 AKAP12 CEACAM1 KIAA1210 FAT2 HPN NHS TLN2 PRKCZ CDH3 PCDH1 | 1.25e-03 | 976 | 159 | 17 | GO:0070161 |
| HumanPheno | Subretinal deposits | 1.27e-05 | 6 | 45 | 3 | HP:0031528 | |
| HumanPheno | Abnormal calvaria morphology | CACNA1C LEMD3 DYNC2H1 BICRA SLC26A4 KIAA0586 ASH1L NSD1 RREB1 KMT2E TRIP12 ADARB1 BRWD3 TUBGCP6 LHX1 PIEZO2 KCNB1 BRCA2 TECPR2 ASXL3 DCHS1 PRKCZ CPLANE1 CSPP1 | 3.06e-05 | 1254 | 45 | 24 | HP:0002683 |
| HumanPheno | Prominent nasal bridge | LEMD3 BICRA KIAA0586 ASH1L NBN RREB1 ASXL3 NHS CPLANE1 CSPP1 | 3.20e-05 | 239 | 45 | 10 | HP:0000426 |
| HumanPheno | Twelfth rib hypoplasia | 7.63e-05 | 2 | 45 | 2 | HP:0006668 | |
| HumanPheno | Early ossification of capital femoral epiphyses | 7.63e-05 | 2 | 45 | 2 | HP:0008797 | |
| MousePheno | decreased carbon dioxide production | 7.74e-06 | 31 | 126 | 5 | MP:0008964 | |
| MousePheno | increased insulin secretion | 2.33e-05 | 64 | 126 | 6 | MP:0003058 | |
| MousePheno | increased skeletal muscle triglyceride level | 3.34e-05 | 21 | 126 | 4 | MP:0031415 | |
| MousePheno | ovary degeneration | 5.77e-05 | 9 | 126 | 3 | MP:0013236 | |
| MousePheno | decreased fatty acid oxidation | 5.81e-05 | 24 | 126 | 4 | MP:0014172 | |
| MousePheno | increased lean body mass | SECISBP2L CEACAM5 PNLIP CEACAM8 CEACAM6 GRIK1 RREB1 WRAP53 CEACAM1 KCNB1 NCOA1 PCDH18 | 8.43e-05 | 354 | 126 | 12 | MP:0003960 |
| MousePheno | increased abdominal fat pad weight | 9.40e-05 | 27 | 126 | 4 | MP:0009286 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 1.64e-04 | 31 | 126 | 4 | MP:0031413 | |
| Domain | Cadherin_CS | PCDHGA3 FAT3 PCDHB13 PCDHB3 PCDHA8 PCDHA6 CDHR5 PCDH17 FAT2 CELSR2 PCDHGB4 DCHS1 CDH3 PCDH1 PCDH18 | 1.93e-14 | 109 | 157 | 15 | IPR020894 |
| Domain | CADHERIN_1 | PCDHGA3 FAT3 PCDHB13 PCDHB3 PCDHA8 PCDHA6 CDHR5 PCDH17 FAT2 CELSR2 PCDHGB4 DCHS1 CDH3 PCDH1 PCDH18 | 3.34e-14 | 113 | 157 | 15 | PS00232 |
| Domain | CADHERIN_2 | PCDHGA3 FAT3 PCDHB13 PCDHB3 PCDHA8 PCDHA6 CDHR5 PCDH17 FAT2 CELSR2 PCDHGB4 DCHS1 CDH3 PCDH1 PCDH18 | 3.82e-14 | 114 | 157 | 15 | PS50268 |
| Domain | - | PCDHGA3 FAT3 PCDHB13 PCDHB3 PCDHA8 PCDHA6 CDHR5 PCDH17 FAT2 CELSR2 PCDHGB4 DCHS1 CDH3 PCDH1 PCDH18 | 3.82e-14 | 114 | 157 | 15 | 2.60.40.60 |
| Domain | CA | PCDHGA3 FAT3 PCDHB13 PCDHB3 PCDHA8 PCDHA6 CDHR5 PCDH17 FAT2 CELSR2 PCDHGB4 DCHS1 CDH3 PCDH1 PCDH18 | 4.36e-14 | 115 | 157 | 15 | SM00112 |
| Domain | Cadherin-like | PCDHGA3 FAT3 PCDHB13 PCDHB3 PCDHA8 PCDHA6 CDHR5 PCDH17 FAT2 CELSR2 PCDHGB4 DCHS1 CDH3 PCDH1 PCDH18 | 4.98e-14 | 116 | 157 | 15 | IPR015919 |
| Domain | Cadherin | PCDHGA3 FAT3 PCDHB13 PCDHB3 PCDHA8 PCDHA6 CDHR5 PCDH17 FAT2 CELSR2 PCDHGB4 DCHS1 CDH3 PCDH1 PCDH18 | 6.45e-14 | 118 | 157 | 15 | IPR002126 |
| Domain | Cadherin | PCDHGA3 FAT3 PCDHB13 PCDHB3 PCDHA8 PCDHA6 PCDH17 FAT2 CELSR2 PCDHGB4 DCHS1 CDH3 PCDH1 PCDH18 | 6.55e-13 | 113 | 157 | 14 | PF00028 |
| Domain | Cadherin_2 | PCDHGA3 PCDHB13 PCDHB3 PCDHA8 PCDHA6 PCDH17 PCDHGB4 PCDH1 PCDH18 | 3.56e-09 | 65 | 157 | 9 | PF08266 |
| Domain | Cadherin_N | PCDHGA3 PCDHB13 PCDHB3 PCDHA8 PCDHA6 PCDH17 PCDHGB4 PCDH1 PCDH18 | 3.56e-09 | 65 | 157 | 9 | IPR013164 |
| Domain | SAPS | 5.83e-07 | 3 | 157 | 3 | IPR007587 | |
| Domain | SAPS | 5.83e-07 | 3 | 157 | 3 | PF04499 | |
| Domain | Cadherin_tail | 2.56e-04 | 37 | 157 | 4 | PF15974 | |
| Domain | Cadherin_CBD | 2.56e-04 | 37 | 157 | 4 | IPR031904 | |
| Domain | Cadherin_C | 4.19e-04 | 42 | 157 | 4 | IPR032455 | |
| Domain | Cadherin_C_2 | 4.19e-04 | 42 | 157 | 4 | PF16492 | |
| Domain | AWS | 6.91e-04 | 5 | 157 | 2 | SM00570 | |
| Domain | AWS | 6.91e-04 | 5 | 157 | 2 | PS51215 | |
| Domain | AWS_dom | 6.91e-04 | 5 | 157 | 2 | IPR006560 | |
| Domain | RCC1/BLIP-II | 9.12e-04 | 23 | 157 | 3 | IPR009091 | |
| Pathway | REACTOME_FIBRONECTIN_MATRIX_FORMATION | 7.90e-06 | 6 | 105 | 3 | M26970 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MYBBP1A LIMA1 AFTPH RPS6KA5 MYCBP2 DAB2 NBN MCM3 RREB1 WRAP53 TERF2 TRIP12 ADARB1 MIER1 IWS1 TUBGCP6 USP10 PPIG WDHD1 SUGP2 MAGED2 SIPA1L1 SAFB2 TLN2 MICAL3 LIMCH1 USP47 PPP6R3 | 2.42e-17 | 774 | 159 | 28 | 15302935 |
| Pubmed | PCDHGA3 PCDHB13 PCDHB3 PCDHA8 PCDHA6 PCDH17 FAT2 CELSR2 PCDHGB4 PCDH1 PCDH18 | 6.62e-14 | 77 | 159 | 11 | 10835267 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDHGA3 PCDHB13 PCDHB3 PCDHA8 PCDHA6 PCDH17 FAT2 CELSR2 PCDHGB4 PCDH1 PCDH18 | 1.03e-13 | 80 | 159 | 11 | 10716726 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDHGA3 PCDHB13 PCDHB3 PCDHA8 PCDHA6 CDHR5 PCDH17 PCDHGB4 PCDH1 PCDH18 | 1.67e-12 | 74 | 159 | 10 | 10817752 |
| Pubmed | MYBBP1A LIMA1 MYCBP2 NSD1 MCM3 CHD8 FYCO1 GRIK2 PPP6R1 AKAP12 USP10 CELSR2 KCNB1 MAGED2 UBR5 PTPRN2 N4BP2 SPHKAP SIPA1L1 DCHS1 SAFB2 TLN2 LIMCH1 PPP6R2 | 1.59e-11 | 963 | 159 | 24 | 28671696 | |
| Pubmed | 4.21e-10 | 4 | 159 | 4 | 26483485 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PRUNE2 CACNA1C MYCBP2 MYO9A SLC38A9 BICRA ASH1L MAGI3 GRIK1 CPD GRIK2 ADARB1 BRWD3 USP10 SLC7A1 SUGP2 TULP4 PTPRN2 TECPR2 PCNX4 HPN TBC1D14 MICAL3 LIMCH1 PRKCZ PCDH1 MGRN1 | 9.31e-10 | 1489 | 159 | 27 | 28611215 |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 1.49e-09 | 72 | 159 | 8 | 10380929 | |
| Pubmed | AFTPH MYO9A KIAA0586 DAB2 PPP6R1 MAGED2 UBR5 SIPA1L1 NHS MICAL3 PPP6R3 | 3.77e-09 | 209 | 159 | 11 | 36779422 | |
| Pubmed | MYBBP1A AFTPH DAB2 NBN MCM3 CHD8 TERF2 TRIP12 IWS1 USP10 SUGT1 NHS TLN2 USP47 PPP6R3 | 1.25e-08 | 503 | 159 | 15 | 16964243 | |
| Pubmed | SECISBP2L PRUNE2 DYNC2H1 KIAA0586 MAGI3 WDR59 FAT2 TULP4 N4BP2 SAFB2 MICAL3 PPP6R2 PCDH18 PDZRN4 | 7.11e-08 | 493 | 159 | 14 | 15368895 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | AFTPH MAGI3 NBN MCM3 CPD SEPTIN8 PJA2 PPIG SUGT1 BRCA2 UBR5 N4BP2 SIPA1L1 MICAL3 CPLANE1 PPP6R2 USP47 PPP6R3 | 8.25e-08 | 853 | 159 | 18 | 28718761 |
| Pubmed | 9.38e-08 | 3 | 159 | 3 | 25409014 | ||
| Pubmed | 9.38e-08 | 3 | 159 | 3 | 17167768 | ||
| Pubmed | 9.38e-08 | 3 | 159 | 3 | 31171910 | ||
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 2.49e-07 | 57 | 159 | 6 | 32633719 | |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | 2.76e-07 | 58 | 159 | 6 | 30377227 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | SECISBP2L FOXO1 AFTPH RBM33 DAB2 FYCO1 PPP6R1 IWS1 SEPTIN8 PJA2 WDHD1 MAGED2 UBR5 TBC1D14 LIMCH1 PPP6R2 HSPB8 USP47 PPP6R3 | 3.14e-07 | 1038 | 159 | 19 | 26673895 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | MYBBP1A RPS6KA5 MAGI3 CHD8 GRIK2 FAM98A F5 IWS1 TUBGCP6 USP10 SIPA1L1 TLN2 LIMCH1 | 3.23e-07 | 475 | 159 | 13 | 31040226 |
| Pubmed | MYBBP1A AFTPH MYCBP2 LEMD3 DYNC2H1 USP11 NBN CPD FAM98A PPP6R1 AKAP12 CEMIP2 PREB TUBGCP6 GRAMD1B PJA2 USP10 SUGT1 UBR5 N4BP2 PPP6R2 CSPP1 PPP6R3 | 3.25e-07 | 1487 | 159 | 23 | 33957083 | |
| Pubmed | 3.74e-07 | 4 | 159 | 3 | 10436421 | ||
| Pubmed | 3.74e-07 | 4 | 159 | 3 | 19621075 | ||
| Pubmed | Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMs. | 3.74e-07 | 4 | 159 | 3 | 27748768 | |
| Pubmed | Helicobacter pylori exploits human CEACAMs via HopQ for adherence and translocation of CagA. | 3.74e-07 | 4 | 159 | 3 | 27748756 | |
| Pubmed | Interdependency of CEACAM-1, -3, -6, and -8 induced human neutrophil adhesion to endothelial cells. | 3.74e-07 | 4 | 159 | 3 | 19077207 | |
| Pubmed | 4.06e-07 | 14 | 159 | 4 | 11994468 | ||
| Pubmed | 4.06e-07 | 14 | 159 | 4 | 20381490 | ||
| Pubmed | 4.06e-07 | 14 | 159 | 4 | 22159884 | ||
| Pubmed | 4.06e-07 | 14 | 159 | 4 | 28567513 | ||
| Pubmed | 4.06e-07 | 14 | 159 | 4 | 8207827 | ||
| Pubmed | CEACAM2 positively regulates integrin αIIbβ3-mediated platelet functions. | 4.06e-07 | 14 | 159 | 4 | 27161904 | |
| Pubmed | 4.06e-07 | 14 | 159 | 4 | 23070997 | ||
| Pubmed | 4.06e-07 | 14 | 159 | 4 | 10491101 | ||
| Pubmed | 5.52e-07 | 15 | 159 | 4 | 24948196 | ||
| Pubmed | 5.52e-07 | 15 | 159 | 4 | 20410265 | ||
| Pubmed | 5.52e-07 | 15 | 159 | 4 | 26586918 | ||
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 7.19e-07 | 68 | 159 | 6 | 11230163 | |
| Pubmed | 7.33e-07 | 16 | 159 | 4 | 25085348 | ||
| Pubmed | Differences in tissue-specific and embryonic expression of mouse Ceacam1 and Ceacam2 genes. | 7.33e-07 | 16 | 159 | 4 | 11284729 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | MYBBP1A MYCBP2 LEMD3 USP11 MCM3 CHD8 FYCO1 TRIP12 USP10 MAGED2 UBR5 PPP6R3 | 9.67e-07 | 440 | 159 | 12 | 34244565 |
| Pubmed | 1.44e-06 | 234 | 159 | 9 | 36243803 | ||
| Pubmed | 1.86e-06 | 6 | 159 | 3 | 20065038 | ||
| Pubmed | 3.24e-06 | 7 | 159 | 3 | 16059920 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | FOXO1 MYO9A RBM33 DYNC2H1 USP11 NBN MCM3 PPP6R1 BRCA2 UBR5 N4BP2 PPP6R2 PPP6R3 | 3.43e-06 | 588 | 159 | 13 | 38580884 |
| Pubmed | ENPP6 USP11 BICRA FAT3 ASH1L NBN CHD8 PPP6R1 BCL7A RREB1 BRWD3 TUBGCP6 PJA2 SUGP2 UBR5 HPN SIPA1L1 TAF7L | 3.89e-06 | 1116 | 159 | 18 | 31753913 | |
| Pubmed | 4.16e-06 | 24 | 159 | 4 | 24698270 | ||
| Pubmed | MYBBP1A LIMA1 VRK3 MCM3 PPP6R1 TERF2 TRIP12 USP10 PPIG ELL2 SUGT1 TULP4 SIPA1L1 NHS LIMCH1 PRKCZ PPP6R2 CDH3 PPP6R3 | 4.67e-06 | 1247 | 159 | 19 | 27684187 | |
| Pubmed | 5.16e-06 | 95 | 159 | 6 | 29490077 | ||
| Pubmed | Protein phosphatase 6 subunit with conserved Sit4-associated protein domain targets IkappaBepsilon. | 5.16e-06 | 8 | 159 | 3 | 16769727 | |
| Pubmed | Protein phosphatase 6 regulatory subunits composed of ankyrin repeat domains. | 5.16e-06 | 8 | 159 | 3 | 18186651 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 6.44e-06 | 212 | 159 | 8 | 33853758 | |
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 7.36e-06 | 101 | 159 | 6 | 24613305 | |
| Pubmed | 7.72e-06 | 9 | 159 | 3 | 21187329 | ||
| Pubmed | Abnormal neocortex arealization and Sotos-like syndrome-associated behavior in Setd2 mutant mice. | 7.91e-06 | 28 | 159 | 4 | 33523829 | |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 7.91e-06 | 28 | 159 | 4 | 15347688 | |
| Pubmed | CACNA1C PCDHB13 RREB1 PREB FOXRED2 TULP4 MAGED2 SIPA1L1 CSPP1 PPP6R3 | 8.83e-06 | 371 | 159 | 10 | 15747579 | |
| Pubmed | MYBBP1A GBP7 RAPGEF5 ASH1L NSD1 TRIP12 MIER1 AKAP12 SEPTIN8 SLC7A1 WDHD1 NFE2L1 SIPA1L1 SAFB2 PRKCZ CPLANE1 PCDH18 | 1.06e-05 | 1084 | 159 | 17 | 11544199 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | FOXO1 LIMA1 AFTPH MYCBP2 MYO9A MAGI3 FAM98A TRIP12 WDR59 PJA2 N4BP2 SIPA1L1 NHS LIMCH1 CSPP1 | 1.06e-05 | 861 | 159 | 15 | 36931259 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | LEMD3 CDHR5 CPD MIER1 CEMIP2 PREB SLC7A1 PIEZO2 CELSR2 MICAL3 PCDH1 PCDH18 | 1.32e-05 | 569 | 159 | 12 | 30639242 |
| Pubmed | PNLIP RPS6KA5 MYO9A RBM33 BICRA DAB2 CHD8 KIAA1549L N4BP2 PRKCZ CPLANE1 | 1.60e-05 | 486 | 159 | 11 | 20936779 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYCBP2 DYNC2H1 USP11 MAGI3 PPP6R1 TRIP12 WDR59 IWS1 PJA2 USP10 SUGT1 UBR5 SIPA1L1 PPP6R2 USP47 PPP6R3 | 1.62e-05 | 1005 | 159 | 16 | 19615732 |
| Pubmed | MCM3 PPP6R1 TRIP12 WDHD1 MAGED2 UBR5 SIPA1L1 PPP6R2 USP47 PPP6R3 | 1.65e-05 | 399 | 159 | 10 | 37536630 | |
| Pubmed | EEFSEC CEACAM5 AFTPH VRK3 LEMD3 RBM33 NSD1 NBN CHD8 FAM98A BCL7A WRAP53 TERF2 IWS1 PREB USP10 ZNF800 SIPA1L1 LIMCH1 PPP6R3 | 1.77e-05 | 1497 | 159 | 20 | 31527615 | |
| Pubmed | RAPGEF5 PPP6R1 GRAMD1B PJA2 SUGP2 UBR5 SPHKAP SIPA1L1 MICAL3 LIMCH1 | 1.96e-05 | 407 | 159 | 10 | 12693553 | |
| Pubmed | 1.97e-05 | 35 | 159 | 4 | 25977363 | ||
| Pubmed | Rab40c regulates focal adhesions and PP6 activity by controlling ANKRD28 ubiquitylation. | 2.00e-05 | 12 | 159 | 3 | 35512830 | |
| Pubmed | AMPK Interactome Reveals New Function in Non-homologous End Joining DNA Repair. | 2.07e-05 | 121 | 159 | 6 | 31900314 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 23941132 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 15673679 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 32015129 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 11182092 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 14724198 | ||
| Pubmed | Bacterial protein domains with a novel Ig-like fold target human CEACAM receptors. | 2.08e-05 | 2 | 159 | 2 | 33522633 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 15539395 | ||
| Pubmed | Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers. | 2.08e-05 | 2 | 159 | 2 | 17201906 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 15130118 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 2317824 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 19461083 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 7696618 | ||
| Pubmed | Expression and novel subunit isoforms of glutamate receptor genes GluR5 and GluR6. | 2.08e-05 | 2 | 159 | 2 | 8260617 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 3220478 | ||
| Pubmed | Haplotypic diversity in human CEACAM genes: effects on susceptibility to meningococcal disease. | 2.08e-05 | 2 | 159 | 2 | 17960155 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 21470677 | ||
| Pubmed | T cell-mediated elimination of cancer cells by blocking CEACAM6-CEACAM1 interaction. | 2.08e-05 | 2 | 159 | 2 | 35141051 | |
| Pubmed | Assessing the role of GLUK5 and GLUK6 at hippocampal mossy fiber synapses. | 2.08e-05 | 2 | 159 | 2 | 15537878 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 15358807 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 8018919 | ||
| Pubmed | Role of GluK1 kainate receptors in seizures, epileptic discharges, and epileptogenesis. | 2.08e-05 | 2 | 159 | 2 | 24760837 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 8776764 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 30321907 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 38502695 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 31222613 | ||
| Pubmed | High expression of CEACAM6 and CEACAM8 mRNA in acute lymphoblastic leukemias. | 2.08e-05 | 2 | 159 | 2 | 17909799 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 11069933 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 12947409 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 11095950 | ||
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 28292985 | ||
| Pubmed | Kainate receptor-mediated synaptic transmission in the adult anterior cingulate cortex. | 2.08e-05 | 2 | 159 | 2 | 15928066 | |
| Pubmed | 2.08e-05 | 2 | 159 | 2 | 2803308 | ||
| Pubmed | Q/R site editing in kainate receptor GluR5 and GluR6 pre-mRNAs requires distant intronic sequences. | 2.08e-05 | 2 | 159 | 2 | 8700852 | |
| Interaction | SPSB4 interactions | 5.55e-07 | 124 | 157 | 9 | int:SPSB4 | |
| Interaction | XAGE1A interactions | 1.61e-05 | 41 | 157 | 5 | int:XAGE1A | |
| Interaction | CEACAM1 interactions | 1.91e-05 | 21 | 157 | 4 | int:CEACAM1 | |
| Interaction | DCLRE1C interactions | 2.04e-05 | 43 | 157 | 5 | int:DCLRE1C | |
| Interaction | NPAS1 interactions | MCM3 PPP6R1 WRAP53 TRIP12 WDR59 PJA2 MAGED2 N4BP2 PPP6R2 HSPB8 | 2.30e-05 | 245 | 157 | 10 | int:NPAS1 |
| Interaction | PCDHGB1 interactions | 3.05e-05 | 77 | 157 | 6 | int:PCDHGB1 | |
| Interaction | RYK interactions | 4.39e-05 | 212 | 157 | 9 | int:RYK | |
| Cytoband | 5q31 | 1.68e-07 | 115 | 159 | 7 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | PCDHGA3 PCDHB13 PCDHB3 PCDHA8 PCDHA6 SEPTIN8 PCDHGB4 PROB1 PCDH1 | 1.10e-06 | 298 | 159 | 9 | chr5q31 |
| GeneFamily | Clustered protocadherins | 1.51e-06 | 64 | 101 | 6 | 20 | |
| GeneFamily | Cadherin related | 2.06e-06 | 17 | 101 | 4 | 24 | |
| GeneFamily | Protein phosphatase 6 regulatory subunits | 3.34e-06 | 6 | 101 | 3 | 699 | |
| GeneFamily | CD molecules|V-set domain containing|Immunoglobulin like domain containing|Carcinoembryonic antigen related cell adhesion molecule family | 8.95e-06 | 24 | 101 | 4 | 906 | |
| GeneFamily | Non-clustered protocadherins | 3.59e-05 | 12 | 101 | 3 | 21 | |
| GeneFamily | Glutamate ionotropic receptor kainate type subunits | 3.06e-04 | 5 | 101 | 2 | 1199 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 5.56e-04 | 29 | 101 | 3 | 396 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 8.93e-04 | 34 | 101 | 3 | 487 | |
| GeneFamily | WD repeat domain containing | 3.52e-03 | 262 | 101 | 6 | 362 | |
| GeneFamily | Ubiquitin specific peptidases | 3.78e-03 | 56 | 101 | 3 | 366 | |
| GeneFamily | LIM domain containing | 4.39e-03 | 59 | 101 | 3 | 1218 | |
| GeneFamily | Immunoglobulin like domain containing | 4.56e-03 | 193 | 101 | 5 | 594 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | SECISBP2L CACNA1C MYCBP2 RBM33 RAPGEF5 LYSMD2 MAGI3 GRIK1 GRIK2 AMER3 KMT2E PCDH17 LHX1 FAT2 PIEZO2 KIAA1549L SUGP2 TULP4 N4BP2 ASXL3 TLN2 MICAL3 PRKCZ PCDH1 PDZRN4 | 1.23e-08 | 1106 | 158 | 25 | M39071 |
| Coexpression | GSE11386_NAIVE_VS_MEMORY_BCELL_DN | 5.47e-06 | 158 | 158 | 8 | M372 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 8.28e-06 | 221 | 158 | 9 | M39222 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | PNLIP RPS6KA5 BICRA KIAA0586 PCDHB13 ASH1L MCM3 CHD8 GRIK1 CPD KMT2E BRWD3 CEMIP2 PJA2 ZNF800 ELL2 ASXL3 SPHKAP INSYN2B CPLANE1 CSPP1 | 4.69e-07 | 804 | 156 | 21 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | FAT3 CNMD PCDHB13 ASH1L DAB2 MCM3 CHD8 GRIK1 CPD KMT2E CEMIP2 HOXA5 LHX1 PJA2 PIEZO2 HOXC6 TULP4 ASXL3 CPLANE1 CSPP1 | 1.80e-06 | 801 | 156 | 20 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | PNLIP BICRA KIAA0586 PCDHB13 ASH1L MCM3 CHD8 CPD KMT2E BRWD3 CEMIP2 HOXA5 LHX1 PJA2 ZNF800 ASXL3 SPHKAP CPLANE1 CSPP1 | 8.88e-06 | 815 | 156 | 19 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | FAT3 CNMD PCDHB13 ASH1L CHD8 GRIK1 CPD KMT2E HOXA5 HOXC6 ASXL3 CPLANE1 CSPP1 | 9.93e-06 | 406 | 156 | 13 | gudmap_developingGonad_e16.5_epididymis_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | AFTPH DYNC2H1 FAT3 KIAA0586 CHD8 IWS1 ZNF800 KIAA1549L CELSR2 NCOA1 NHS | 1.33e-05 | 298 | 156 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | RPS6KA5 MYO9A SLC38A9 PCDHB13 ASH1L MCM3 CHD8 CPD TEX15 KMT2E ADARB1 ZNF800 ELL2 BRCA2 TAF7L INSYN2B CPLANE1 CSPP1 | 1.66e-05 | 776 | 156 | 18 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.51e-05 | 123 | 156 | 7 | gudmap_developingGonad_e12.5_epididymis_k4_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.62e-05 | 84 | 156 | 6 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | FAT3 PCDHB13 ASH1L CHD8 GRIK1 CPD KMT2E HOXA5 LHX1 HOXC6 ASXL3 CPLANE1 | 5.66e-05 | 413 | 156 | 12 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.30e-05 | 59 | 156 | 5 | gudmap_developingLowerUrinaryTract_adult_ureter_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | FAT3 CNMD PCDHB13 ASH1L MCM3 CHD8 GRIK1 CPD KMT2E HOXA5 LHX1 PJA2 HOXC6 TULP4 ASXL3 CPLANE1 CSPP1 | 7.35e-05 | 790 | 156 | 17 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | AFTPH GBP7 MYO9A KIAA0586 PCDHB13 ASH1L CHD8 CPD TEX15 KMT2E PJA2 ZNF800 ELL2 TAF7L INSYN2B CPLANE1 CSPP1 | 7.93e-05 | 795 | 156 | 17 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_1000 | 9.11e-05 | 99 | 156 | 6 | gudmap_developingGonad_e14.5_ epididymis_1000_k1 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | PNLIP RPS6KA5 MYO9A USP11 FAT3 DAB2 TEX15 BRWD3 HOXA5 HOXC6 WDHD1 BRCA2 ASXL3 TAF7L CDH3 CSPP1 PCDH18 | 1.35e-04 | 831 | 156 | 17 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | AFTPH MYO9A RBM33 DYNC2H1 FAT3 KIAA0586 ASH1L CPD IWS1 SEPTIN8 PPIG ZNF800 KIAA1549L BRCA2 UBR5 SAFB2 MICAL3 | 1.35e-04 | 831 | 156 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | ENPP6 PRUNE2 RPS6KA5 MYCBP2 DAB2 CPD TRIP12 BRWD3 PCDH17 AKAP12 KIAA1549L KCNB1 NEURL1B CPLANE1 HSPB8 MGRN1 | 1.85e-04 | 772 | 156 | 16 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_100 | 1.89e-04 | 72 | 156 | 5 | gudmap_developingGonad_e18.5_ovary_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_500 | 2.08e-04 | 40 | 156 | 4 | gudmap_developingGonad_e16.5_epididymis_500_k5 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.15e-04 | 74 | 156 | 5 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500 | 2.22e-04 | 165 | 156 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | GBP7 FAT3 CNMD PCDHB13 ASH1L CHD8 GRIK1 CPD KMT2E HOXA5 LHX1 PJA2 HOXC6 ASXL3 CPLANE1 CSPP1 | 2.73e-04 | 799 | 156 | 16 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | KIAA0586 ASH1L MCM3 CHD8 CPD RREB1 KMT2E TERF2 CEMIP2 LHX1 PJA2 HOXC6 ELL2 ASXL3 CPLANE1 CSPP1 | 3.00e-04 | 806 | 156 | 16 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 3.12e-04 | 124 | 156 | 6 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K5 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | EEFSEC MYBBP1A MYO9A KIAA0586 SYT9 TEX15 LHX1 ELL2 WDHD1 BRCA2 UBR5 TAF7L METTL25 CPLANE1 CDH3 CSPP1 | 3.17e-04 | 810 | 156 | 16 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_100 | 3.46e-04 | 19 | 156 | 3 | gudmap_developingGonad_e18.5_ovary_100_k1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.03e-04 | 130 | 156 | 6 | gudmap_developingGonad_e12.5_ovary_k1_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.74e-04 | 187 | 156 | 7 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | MYBBP1A PNLIP USP11 MCM3 CHD8 CPD PPP6R1 KMT2E CEMIP2 HOXA5 LHX1 PJA2 HOXC6 ASXL3 CSPP1 PCDH18 | 4.91e-04 | 843 | 156 | 16 | gudmap_developingGonad_e11.5_testes_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.96e-04 | 50 | 156 | 4 | gudmap_developingGonad_e12.5_testes_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_500 | 4.96e-04 | 50 | 156 | 4 | gudmap_developingGonad_e14.5_ epididymis_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | ASH1L CHD8 CPD TEX15 ZNF800 ELL2 TAF7L INSYN2B CPLANE1 CSPP1 | 5.41e-04 | 382 | 156 | 10 | gudmap_developingGonad_e14.5_ ovary_500 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-07 | 178 | 158 | 8 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 2.71e-07 | 180 | 158 | 8 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.48e-07 | 186 | 158 | 8 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.61e-07 | 193 | 158 | 8 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.79e-07 | 194 | 158 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-07 | 195 | 158 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.98e-07 | 195 | 158 | 8 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-07 | 195 | 158 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 5.38e-07 | 197 | 158 | 8 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-06 | 166 | 158 | 7 | 548d0d6c0ffd564036ddba78620734220ebb73d7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-06 | 166 | 158 | 7 | 80e164a89d22098cabe4a99a78283ba69ea0561e | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.28e-06 | 167 | 158 | 7 | dbd2b9f2f4ba7be5fdf8318094e6b078cb1d1c43 | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 2.56e-06 | 170 | 158 | 7 | 4a19c7e3bb0f9c2601a10debe7000066789b4150 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.88e-06 | 173 | 158 | 7 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-06 | 175 | 158 | 7 | 31f0fb2e47e357dbf9c15436b7df85b3c370ded7 | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 3.48e-06 | 178 | 158 | 7 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.74e-06 | 180 | 158 | 7 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-06 | 181 | 158 | 7 | a53f05c4c47465ee62e353716456bd09ab464b23 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-06 | 186 | 158 | 7 | 41f1674afc17661eccaa779cdeb663db5e45685d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.64e-06 | 186 | 158 | 7 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-06 | 186 | 158 | 7 | aa006650cf21a2c51dfe1091681f67fdad939107 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.81e-06 | 187 | 158 | 7 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.81e-06 | 187 | 158 | 7 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.81e-06 | 187 | 158 | 7 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 4.98e-06 | 188 | 158 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.98e-06 | 188 | 158 | 7 | d8decd9b5967873ca8320c2f9f07365f163c777f | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 4.98e-06 | 188 | 158 | 7 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.16e-06 | 189 | 158 | 7 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.16e-06 | 189 | 158 | 7 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.53e-06 | 191 | 158 | 7 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.53e-06 | 191 | 158 | 7 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.53e-06 | 191 | 158 | 7 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.72e-06 | 192 | 158 | 7 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.72e-06 | 192 | 158 | 7 | 3ce5dbde41aeb73d49f2c7991d34682f0827fa5a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.72e-06 | 192 | 158 | 7 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.92e-06 | 193 | 158 | 7 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Necab1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.93e-06 | 126 | 158 | 6 | a4fc7ac4931d2fc8aa8196a62d809b698937aa9c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.12e-06 | 194 | 158 | 7 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.12e-06 | 194 | 158 | 7 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.12e-06 | 194 | 158 | 7 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | Endothelial_cells-Endothelial-B|Endothelial_cells / lung cells shred on cell class, cell subclass, sample id | 6.55e-06 | 196 | 158 | 7 | 36f95f9ef74eb951e41ef46fd136ceaef45208fc | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.77e-06 | 197 | 158 | 7 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-APOE+_Mac1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.77e-06 | 197 | 158 | 7 | 121ec3f6d978de2f6c2cc397f7327d2e5587ab8b | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.77e-06 | 197 | 158 | 7 | eb07545bef5ad506fbbe3a1f99131f26c1447a31 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.99e-06 | 198 | 158 | 7 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.99e-06 | 198 | 158 | 7 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.23e-06 | 199 | 158 | 7 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.23e-06 | 199 | 158 | 7 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Myeloid-Megakaryocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.23e-06 | 199 | 158 | 7 | 6e7f7214317f2af2ba8523df9896f54b7294d58a | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Myeloid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.23e-06 | 199 | 158 | 7 | 5f499595597c10857bba8272f62afe4d32d733ac | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / Treatment groups by lineage, cell group, cell type | 7.47e-06 | 200 | 158 | 7 | b036f5e22c95a3b14391785b6e91aa183b9bc9a8 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.47e-06 | 200 | 158 | 7 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.47e-06 | 200 | 158 | 7 | b1be27d134a8633e3e7862c6a0d7be2001d387f0 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.47e-06 | 200 | 158 | 7 | cad2d972aa6ea0cc9ebe5ec60fda6e306e9ee2b2 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 7.47e-06 | 200 | 158 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.00e-05 | 138 | 158 | 6 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.73e-05 | 152 | 158 | 6 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_C|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.01e-05 | 156 | 158 | 6 | 6c8f442ed94ae31e6832b68137e98ae78091ac6c | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.31e-05 | 160 | 158 | 6 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.31e-05 | 160 | 158 | 6 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.31e-05 | 160 | 158 | 6 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.40e-05 | 161 | 158 | 6 | b81b346309f3facbfbebd91cae4c5b33c7bd24ef | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 2.40e-05 | 161 | 158 | 6 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.57e-05 | 163 | 158 | 6 | ec9a20cfe0d69430f9c68cddd1ab0e4a3e4554b8 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-05 | 168 | 158 | 6 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-05 | 168 | 158 | 6 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.15e-05 | 169 | 158 | 6 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 3.15e-05 | 169 | 158 | 6 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l5|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.15e-05 | 169 | 158 | 6 | a388e53deac861a185c31e9cceddae7bcb344700 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.36e-05 | 171 | 158 | 6 | fdd96c6fe850bd10e1e0d0f18c4401f8348b7d2c | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.71e-05 | 174 | 158 | 6 | 42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.71e-05 | 174 | 158 | 6 | 5f4436863a40f8bca46e2989bca66c02b6be88d4 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-05 | 175 | 158 | 6 | c1c722db42da9b8a2a46e516ddb83d9be5e2e504 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.83e-05 | 175 | 158 | 6 | 77c16e615c0fb9c83f29d7e0a547be72635fac81 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.83e-05 | 175 | 158 | 6 | 282f09bbdfa70d93b3f66591dcfb84c5ee0268c7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-05 | 176 | 158 | 6 | 25ebc8716aa44e44fce577701e3e82c6745a75ab | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.95e-05 | 176 | 158 | 6 | d30241fb8119834d6e7b59efec3f92fc7a3d1247 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-05 | 176 | 158 | 6 | c2c4306476989bc2fb30dab00250ef7915842f13 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.95e-05 | 176 | 158 | 6 | cb8fd56a4f935cdda19d7ab43382cdda7c307667 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.08e-05 | 177 | 158 | 6 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | RV-11._Adipocyte|World / Chamber and Cluster_Paper | 4.08e-05 | 177 | 158 | 6 | f0edf04930692418953e4f00a917257804ec0ffd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-05 | 177 | 158 | 6 | 8e4005fad50e6f919da175f3b9ae58849dbd60b1 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.08e-05 | 177 | 158 | 6 | 30f82b04e48940bfcaf2c22677efe6d57ae3f1a7 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.08e-05 | 177 | 158 | 6 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.08e-05 | 177 | 158 | 6 | 0e74980a7686c31fcf1476b8f19a3392541df240 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.08e-05 | 177 | 158 | 6 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.21e-05 | 178 | 158 | 6 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-05 | 179 | 158 | 6 | a09647750eba9d93c5efc1db3b555fefb5eec7b5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.34e-05 | 179 | 158 | 6 | 1ac79c82c52fa95bb4e170ab20fec0f648db2134 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.34e-05 | 179 | 158 | 6 | d5763912a4ce7188535675e338799b856edb9dda | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.48e-05 | 180 | 158 | 6 | baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.48e-05 | 180 | 158 | 6 | 2d608b9394d28d19cfc85c6ac94003d5177c8a92 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.48e-05 | 180 | 158 | 6 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.48e-05 | 180 | 158 | 6 | 0f9b27054358c4737eed06c8ea01987cccc3cb55 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-05 | 181 | 158 | 6 | 30729f0364f719c044712a51453e22dc2c1a232b | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 4.62e-05 | 181 | 158 | 6 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.62e-05 | 181 | 158 | 6 | 9cd5e5c285c2b628db9d59709af053defd7c0aff | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.76e-05 | 182 | 158 | 6 | 997d37ca2af661c92a56add888762724dfccc890 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-05 | 182 | 158 | 6 | f96095b81188b52db8fcfca4837129cfcd9bd7b7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.76e-05 | 182 | 158 | 6 | 205d9ad1ea4b7adee8054496cdde46c9c401a19a | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A | VRK3 RPS6KA5 KIAA0586 DAB2 CHD8 WDR59 HOXA5 SEPTIN8 HOXC6 SUGP2 | 6.03e-07 | 181 | 159 | 10 | 1791_DN |
| Drug | Danazol [17230-88-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A | FOXO1 VRK3 RPS6KA5 MYO9A CPD FYCO1 WRAP53 WDHD1 NCOA1 PPP6R3 | 1.19e-06 | 195 | 159 | 10 | 5315_DN |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 8.21e-06 | 191 | 159 | 9 | 4442_UP | |
| Drug | Pergolide mesylate [66104-23-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.10e-05 | 198 | 159 | 9 | 7031_DN | |
| Drug | clozapine; Down 200; 10uM; MCF7; HT_HG-U133A_EA | MYBBP1A DYNC2H1 WDR59 FOXRED2 SUGP2 TECPR2 NCOA1 PPP6R2 CSPP1 | 1.10e-05 | 198 | 159 | 9 | 1009_DN |
| Disease | Joubert syndrome with Jeune asphyxiating thoracic dystrophy | 2.74e-05 | 2 | 155 | 2 | C4518774 | |
| Disease | Joubert syndrome 1 | 1.76e-04 | 21 | 155 | 3 | C4551568 | |
| Disease | JOUBERT SYNDROME 17 | 2.71e-04 | 5 | 155 | 2 | C3553264 | |
| Disease | upper aerodigestive tract neoplasm | 3.36e-04 | 246 | 155 | 7 | EFO_0004284 | |
| Disease | body weight | SECISBP2L FOXO1 CACNA1C GTF2A1L RPS6KA5 DAB2 CHD8 GRIK2 BCL7A TRIP12 WDR59 SLC7A1 TULP4 ASXL3 SPHKAP TLN2 PDZRN4 | 3.57e-04 | 1261 | 155 | 17 | EFO_0004338 |
| Disease | neutrophil count | FOXO1 PRUNE2 LIMA1 MYCBP2 ZNF391 DYNC2H1 ASH1L NSD1 MAGI3 PCDHA8 PCDHA6 RREB1 KMT2E AKAP12 TBC1D14 NCOA1 TLN2 USP47 | 3.59e-04 | 1382 | 155 | 18 | EFO_0004833 |
| Disease | Familial aplasia of the vermis | 5.20e-04 | 30 | 155 | 3 | C0431399 | |
| Disease | peripheral vascular disease | 5.66e-04 | 7 | 155 | 2 | EFO_0003875 | |
| Disease | HWESASXX measurement | 5.66e-04 | 7 | 155 | 2 | EFO_0021147 | |
| Disease | amyloid-beta measurement | 6.03e-04 | 355 | 155 | 8 | EFO_0005194 | |
| Disease | lymphocyte count | LIMA1 SLC38A9 PCDHGA3 SLC26A4 NSD1 RRN3P2 NBN PCDHA6 RREB1 TRIP12 NFE2L3 GRAMD1B ZNF800 DCLRE1C TBC1D14 PCDHGB4 MICAL3 NEURL1B | 7.05e-04 | 1464 | 155 | 18 | EFO_0004587 |
| Disease | diastolic blood pressure, systolic blood pressure | CACNA1C MYO9A RBM33 DYNC2H1 KMT2E TERF2 ZNF800 PIEZO2 KCNB1 N4BP2 TLN2 | 8.63e-04 | 670 | 155 | 11 | EFO_0006335, EFO_0006336 |
| Disease | macrovascular complications of diabetes | 1.20e-03 | 10 | 155 | 2 | EFO_0010977 | |
| Disease | Macrocephaly | 1.46e-03 | 11 | 155 | 2 | C0221355 | |
| Disease | Neurodevelopmental Disorders | 1.49e-03 | 93 | 155 | 4 | C1535926 | |
| Disease | Prostatic Neoplasms | FOXO1 MYBBP1A SLC26A4 ASH1L NBN SLC7A1 BRCA2 HPN NCOA1 PRKCZ | 1.61e-03 | 616 | 155 | 10 | C0033578 |
| Disease | Malignant neoplasm of prostate | FOXO1 MYBBP1A SLC26A4 ASH1L NBN SLC7A1 BRCA2 HPN NCOA1 PRKCZ | 1.61e-03 | 616 | 155 | 10 | C0376358 |
| Disease | Short Rib-Polydactyly Syndrome | 2.06e-03 | 13 | 155 | 2 | C0036996 | |
| Disease | unipolar depression, mood disorder, response to antidepressant | 2.39e-03 | 14 | 155 | 2 | EFO_0003761, EFO_0004247, GO_0036276 | |
| Disease | femoral neck bone geometry | 2.39e-03 | 14 | 155 | 2 | EFO_0004511 | |
| Disease | Saldino-Noonan Syndrome | 2.39e-03 | 14 | 155 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 2.39e-03 | 14 | 155 | 2 | C0024507 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 2.39e-03 | 14 | 155 | 2 | C0677776 | |
| Disease | Autistic Disorder | 2.64e-03 | 261 | 155 | 6 | C0004352 | |
| Disease | response to cisplatin, platinum measurement | 2.75e-03 | 53 | 155 | 3 | EFO_0010154, GO_0072718 | |
| Disease | Yu-Zhi constitution type | 2.75e-03 | 15 | 155 | 2 | EFO_0007638 | |
| Disease | factor VII activating protease measurement | 3.05e-03 | 55 | 155 | 3 | EFO_0009368 | |
| Disease | Congenital total cataract | 3.13e-03 | 16 | 155 | 2 | C0266539 | |
| Disease | ovarian cancer (is_implicated_in) | 3.21e-03 | 56 | 155 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | Polydactyly | 3.43e-03 | 117 | 155 | 4 | C0152427 | |
| Disease | Nuclear non-senile cataract | 3.97e-03 | 18 | 155 | 2 | C1112705 | |
| Disease | Nuclear cataract | 3.97e-03 | 18 | 155 | 2 | C0392557 | |
| Disease | cutaneous melanoma, hair color | 4.29e-03 | 62 | 155 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 4.42e-03 | 19 | 155 | 2 | C0751884 | |
| Disease | maximal midexpiratory flow rate | 4.90e-03 | 20 | 155 | 2 | EFO_0004313 | |
| Disease | serum carcinoembryonic antigen measurement | 4.90e-03 | 20 | 155 | 2 | EFO_0005760 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ANTNNPSADEFADHL | 491 | A8MVM7 | |
| SVEQLASPAQNEASD | 291 | Q8N944 | |
| PASSEQAQQELFNEL | 421 | Q07001 | |
| SSSDFFESEDQLQDP | 931 | Q9NR48 | |
| TDDSFNQVTQDPIEE | 21 | Q9HCK8 | |
| GTQDLPVDSFSQNDS | 406 | O00472 | |
| DPENQNSALADTDAS | 1706 | Q02952 | |
| TNFQSPNIDPTEEND | 391 | Q6ULP2 | |
| FITSNNSNPVEDEDA | 326 | P06731 | |
| SNNSNPVEDKDAVAF | 151 | P31997 | |
| NPDSDVVENNFTLLN | 611 | P39086 | |
| DDSDNDNFVSTEDPL | 1761 | Q6RI45 | |
| FLSVEDDNDNAPQFS | 386 | Q9HCU4 | |
| QAQDPEFSDLNSAIT | 386 | Q9HBB8 | |
| NSPSLDFNDNEDIPT | 336 | Q3KR37 | |
| PVQNFADSSNADELE | 2196 | Q9C0F0 | |
| FNPVQASQLEEEFDS | 461 | Q14494 | |
| LLQSDNEDEENFSSQ | 71 | Q96EV2 | |
| ESSEQENAAEDPNST | 566 | Q6ZMN7 | |
| LNSINLSFQDDPDSS | 271 | Q96L73 | |
| EIQDINDNAPSFSSD | 121 | O14917 | |
| VTDSENDEPLNLNAS | 66 | Q96ST2 | |
| NDEPLNLNASDSESE | 71 | Q96ST2 | |
| QAEPNSSFVAQREEN | 756 | Q92932 | |
| LVTDANDNAPVFSQD | 231 | Q9UN71 | |
| ISDSNDNSPAFEQQS | 236 | Q9HCL0 | |
| TVLDVNDNAPTFEQS | 231 | Q9UN73 | |
| NDLFQVNSTSDDEIP | 816 | Q9UPP5 | |
| ASAPQQLSDEELFSQ | 6 | Q9Y2U8 | |
| DQDPDSNQTIFASTL | 341 | A5PLL1 | |
| SEIDTNQNSLRENPF | 241 | P98082 | |
| VEDVNDNAPAFSQSL | 2366 | Q96JQ0 | |
| IADVNDNAPAFTQTS | 441 | Q9Y5F0 | |
| TVLDVNDNAPTFEQS | 231 | Q9Y5H6 | |
| NPNFEVAESDFTNNA | 696 | P58215 | |
| EAADFSTQQQLPSLD | 341 | Q7RTP6 | |
| ESAAAQSQENQDTRP | 156 | Q9UNF1 | |
| QPEDDSSQAFISTQN | 816 | Q5TCQ9 | |
| IDSPENETADNSFSQ | 131 | Q8IV50 | |
| NETADNSFSQEEEPV | 136 | Q8IV50 | |
| SDEDDNSFLKQQSPQ | 686 | Q9UHB6 | |
| ENPNNFQEVAADSSS | 61 | P16233 | |
| SNFDLNSPLNNEALE | 216 | Q9BQS8 | |
| SNNSNPVEDKDAVAF | 151 | P40199 | |
| TFGESSFNNELPQDS | 176 | Q9UJY1 | |
| NQETKPSDDENSDNS | 261 | O60291 | |
| ADTEEVFNNSPTNQE | 256 | Q8N6Q8 | |
| ATQNAEEQPSTFSEN | 561 | Q8N448 | |
| SPEDIDSLNSETFND | 806 | Q63HM2 | |
| ITDENDNAPRFASEE | 2896 | Q9NYQ8 | |
| IEVQDINDNTPNFAS | 156 | Q08174 | |
| PNLATSNAENLEDAA | 721 | Q1MSJ5 | |
| EDAPASSEQASAQSE | 151 | P20719 | |
| SLATEDNFDPIDVSQ | 396 | Q9Y4A8 | |
| SDFEQLPDDVAISAN | 11 | Q15080 | |
| SVSNNQEPDFIDDIE | 536 | Q8IZD2 | |
| QDPSQDDAKDSESAN | 146 | P48742 | |
| SSPDENENEDSADFV | 156 | Q9H0R5 | |
| QIEAAENEEPSVFSQ | 581 | Q8N8V2 | |
| EDEGFQSASNLTPDS | 256 | Q96RT7 | |
| TAASQQSLAENDPSD | 1801 | Q6ZVL6 | |
| ADSNNPETLFQFSDS | 786 | O75582 | |
| FEESETEQNNSSQPS | 396 | Q9Y546 | |
| QSADSITLPQDDNDN | 311 | Q8IWF2 | |
| VNTDFTSDQADFPDT | 161 | P78563 | |
| FRDPNSEENSNDIAL | 246 | P05981 | |
| QPDLDSLVDFSTNNQ | 416 | Q9BQG0 | |
| SSESEAENLEAQPQS | 256 | Q13427 | |
| AQDFSSEQGRTAPQD | 101 | P09630 | |
| IFSVTAQDPDSNNNA | 471 | Q9Y5H0 | |
| ILATDDPNFSQEDQQ | 526 | P25205 | |
| SSASELNETQEPFLN | 16 | O43614 | |
| SFDGNQLSENQLDSP | 4226 | Q8NCM8 | |
| DTLDFNFDNVLPNQS | 626 | Q12778 | |
| SLDEFGQSTDNPQLA | 216 | Q14721 | |
| NDEITDESLENFPSS | 496 | Q96SD1 | |
| PFPEDDSNATNSNLE | 146 | Q13936 | |
| NPDSEELFSDNENNF | 876 | P51587 | |
| TFRPENSIINNDDSE | 2491 | Q9H799 | |
| SNNSNPVEDKDAVAF | 151 | P13688 | |
| VFADSDDENLNTESP | 91 | Q9H9R9 | |
| TDPQQRQQASEADAA | 6 | P07902 | |
| ISENEFASEAEQSTP | 3461 | Q8N3K9 | |
| VEDANDNSPVFIQDS | 821 | Q8TDW7 | |
| KDLDTDFTNNASQPE | 1061 | O75976 | |
| DRATFAFSPEEQQAQ | 56 | Q9UHN6 | |
| EEQSDQSFSSLEPDN | 61 | Q8NA54 | |
| VSSASNNTPEEQNDF | 891 | Q9ULL0 | |
| PTDINFANAVSDALD | 161 | Q6UWR7 | |
| NPDSDVVENNFTLLN | 596 | Q13002 | |
| DDNSNQSSIADASPI | 91 | Q4VC05 | |
| DVDQASFSSDSPQDD | 1481 | Q9NZM4 | |
| EQNFLDNFPSSDTLS | 426 | Q8NBW4 | |
| QEPALFSTDNDDFTV | 61 | P22223 | |
| AEINFNIDADEDSPS | 601 | O75170 | |
| ESQLFDPSDLQDTSN | 96 | Q9UPQ0 | |
| DETQSSNDDPSQSVA | 126 | Q8N108 | |
| SNDDPSQSVASQDAQ | 131 | Q8N108 | |
| RSNSAEPNSAEQDEA | 326 | Q68BL7 | |
| VSDVNDNAPAFTQIS | 441 | Q9Y5E6 | |
| PALEDSLSQEVQDSF | 496 | Q7Z6I6 | |
| EVSVDQQFSPDLNDN | 941 | Q9H195 | |
| TNEQENSEDFLDPPT | 106 | Q86SS6 | |
| DADSSAQAAAQAPEN | 66 | Q5H9L4 | |
| TQLANEEDNPDDTSS | 1521 | Q2M3C7 | |
| EEDNPDDTSSFLQLS | 1526 | Q2M3C7 | |
| QELSENTSLPAEEAN | 96 | Q9BUR4 | |
| SELLDNSPSEINNEA | 846 | Q8WUY3 | |
| NSSLNQEEEEFNLTA | 741 | P12259 | |
| ELQQAPQAQESFSDS | 51 | A6NCL1 | |
| VADLLDDPNNSNTSD | 706 | Q6T4R5 | |
| NEPVDTNSDNNLFTD | 511 | O60934 | |
| ENVQATNSPSEAEEF | 61 | Q8NCA5 | |
| DPQQTASLTESFNGD | 386 | Q14872 | |
| LEAQSQFTADLDQFD | 801 | Q15788 | |
| LADTLNPFAENEESQ | 321 | Q92565 | |
| PLSAASNSDQLEDQA | 1706 | O43166 | |
| DASQQTDFPSDIANK | 216 | Q93073 | |
| ENANSQPNDEDASSD | 3996 | O75592 | |
| ADDREAQQQFTEPAF | 126 | E7EW31 | |
| LQQADNFPEAFSTEV | 106 | Q8IYE0 | |
| EVSNFLEDVNQSTPN | 276 | Q86WS4 | |
| RPSVQEDSQAFNPDN | 246 | O75829 | |
| SSAIVTLENDDDPQF | 186 | Q9P2M4 | |
| TLENDDDPQFTNVTL | 191 | Q9P2M4 | |
| VENLQAVQTDFSSDP | 141 | Q9HCU5 | |
| LNKTNEFQDSSESEP | 1396 | Q9NRJ4 | |
| DNFDQEPILDSFNFS | 356 | P57772 | |
| SDAVSTNNAFEPDED | 606 | O43511 | |
| AVSENEAELAPNASN | 1596 | Q92766 | |
| SATNSSDNEDPQVNI | 396 | Q9UNN4 | |
| DPADQNELASTNDSQ | 451 | P30825 | |
| SNILSDNPDFSDEAD | 1031 | O75717 | |
| EIEQFSIENSTDNPD | 801 | Q8IX01 | |
| PSSHDAANFDNNELE | 216 | A8MQ27 | |
| EAAQSNPEFENEELA | 151 | Q9H5I5 | |
| QTSDPENFQSEERSD | 931 | Q96K76 | |
| QDSDGDSQPFSLQET | 311 | Q92599 | |
| VDQLSAESPDQESSF | 516 | O15040 | |
| NVTAENIFVDPEDQS | 306 | Q8IV63 | |
| EESSELEQPFAQDTS | 231 | Q14151 | |
| QSFSDALIDEDPQAA | 16 | Q9Y2Z0 | |
| DDNLPANFDTSQSLA | 176 | A6NIE6 | |
| ANITFSLNADDENPN | 591 | Q9UPN7 | |
| LESFVNQEDSASSNP | 491 | Q6PJI9 | |
| PFQEAQSELNQAAAD | 1236 | Q9Y4G6 | |
| ANSAVPNSVSAEDAE | 181 | Q14694 | |
| PQESQADLETSDNSD | 211 | Q2TB10 | |
| PQDTFDLEEVQSNSE | 481 | A2RU30 | |
| ETLNANINSTNFAPD | 56 | Q6P9G4 | |
| QLNESTSATEADQDP | 491 | Q9H0C3 | |
| ENQNSESLFTEPSNV | 871 | Q9BXT5 | |
| LDTNPEINQSDSQDS | 1566 | Q14669 | |
| ASPFENTENATITDQ | 401 | Q5H9R7 | |
| SSSDEGNEPANEFAQ | 511 | O43164 | |
| DLDFSEFVIQPQNES | 851 | P51784 | |
| LFQVQAAPDEDSTTN | 471 | Q15554 | |
| QENDVNLPVAAEDFS | 1411 | Q9BVV6 | |
| TTISNSQLFEQDDNP | 86 | Q9UK12 | |
| SVPAFFSEDDSQSND | 1656 | O95071 | |
| AAQESSNDQFQTLEE | 156 | Q3MJ62 | |
| ESSEFSLSPNLDAQQ | 61 | Q9UJN7 | |
| EQTANNPTESDTLEF | 356 | A6NMK8 | |
| DNFDTQFTSEPVQLT | 546 | Q05513 | |
| NELSTPSSDQDAFNL | 1556 | Q9NR99 | |
| PSQDVNSFNDSSEFI | 166 | Q86UW6 | |
| DEESNFPQATNQTLL | 611 | B2RTY4 |